NUVB
NYSE · Pharmaceuticals
Nuvation Bio Inc
$4.16
-0.03 (-0.72%)
Open$4.21
Previous Close$4.19
Day High$4.33
Day Low$3.98
52W High$9.75
52W Low$4.05
Volume—
Avg Volume5.44M
Market Cap1.48B
P/E Ratio—
EPS$-0.44
SectorPharmaceuticals
Analyst Ratings
Strong Buy
19 analysts
Price Target
+938.9% upside
Current
$4.16
$4.16
Target
$43.22
$43.22
$30.63
$43.22 avg
$69.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 57.46M | 781.90M | 798.00M |
| Net Income | -186,873,146 | 141.36M | 136.11M |
| Profit Margin | -325.3% | 18.1% | 17.1% |
| EBITDA | -192,986,839 | 195.91M | 227.47M |
| Free Cash Flow | — | 85.45M | 83.04M |
| Rev Growth | — | +23.6% | -6.7% |
| Debt/Equity | 0.68 | 0.84 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |